328 related articles for article (PubMed ID: 25596550)
1. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H
ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
[TBL] [Abstract][Full Text] [Related]
3. The design, annotation, and application of a kinase-targeted library.
Xi H; Lunney EA
Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
[TBL] [Abstract][Full Text] [Related]
4. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
5. Fragment-based approaches to the discovery of kinase inhibitors.
Mortenson PN; Berdini V; O'Reilly M
Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase profiling assays: a technology review.
Wang Y; Ma H
Drug Discov Today Technol; 2015 Nov; 18():1-8. PubMed ID: 26723886
[TBL] [Abstract][Full Text] [Related]
7. System-based drug discovery within the human kinome.
Bamborough P
Expert Opin Drug Discov; 2012 Nov; 7(11):1053-70. PubMed ID: 22971083
[TBL] [Abstract][Full Text] [Related]
8. What general conclusions can we draw from kinase profiling data sets?
Sutherland JJ; Gao C; Cahya S; Vieth M
Biochim Biophys Acta; 2013 Jul; 1834(7):1425-33. PubMed ID: 23333421
[TBL] [Abstract][Full Text] [Related]
9. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
[TBL] [Abstract][Full Text] [Related]
10. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
Hantschel O
ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
[TBL] [Abstract][Full Text] [Related]
11. Kinase profiling in early stage drug discovery: sorting things out.
Defert O; Boland S
Drug Discov Today Technol; 2015 Nov; 18():52-61. PubMed ID: 26723893
[TBL] [Abstract][Full Text] [Related]
12. The resistance tetrad: amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles.
Bailey FP; Andreev VI; Eyers PA
Methods Enzymol; 2014; 548():117-46. PubMed ID: 25399644
[TBL] [Abstract][Full Text] [Related]
13. Trends in kinase selectivity: insights for target class-focused library screening.
Posy SL; Hermsmeier MA; Vaccaro W; Ott KH; Todderud G; Lippy JS; Trainor GL; Loughney DA; Johnson SR
J Med Chem; 2011 Jan; 54(1):54-66. PubMed ID: 21128601
[TBL] [Abstract][Full Text] [Related]
14. Protocols for the Design of Kinase-focused Compound Libraries.
Jacoby E; Wroblowski B; Buyck C; Neefs JM; Meyer C; Cummings MD; van Vlijmen H
Mol Inform; 2018 May; 37(5):e1700119. PubMed ID: 29116686
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium kinases as targets for new-generation antimalarials.
Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
[TBL] [Abstract][Full Text] [Related]
17. Current compound coverage of the kinome.
Hu Y; Furtmann N; Bajorath J
J Med Chem; 2015 Jan; 58(1):30-40. PubMed ID: 25051177
[TBL] [Abstract][Full Text] [Related]
18. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
Fabbro D
Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
[TBL] [Abstract][Full Text] [Related]
19. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
20. Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
Zhu LX; Liu Q; Hua YF; Yang N; Zhang XG; Ding X
Comput Biol Chem; 2019 Jun; 80():324-332. PubMed ID: 31078911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]